Tuesday 17 November 2026 · UTC
Global

Your region, kept on this device.

MalwareMustDie releases open ARTEX detection pack built on attacker behaviour

Compiled by RedTeamDaily · AI-assisted summaries · Human review not recorded for this version

Published

Read Security Affairs report

What happened

The MalwareMustDie ARTEX pack (currently v1.1.3, with later updates adding flash report data and confirmed Sophos X-Ops indicators) is behaviour-first: Sigma correlation rules, Sentinel KQL, Suricata 7, Snort 3, osquery, YARA and STIX 2.1, with IOCs expiring after one year. Defenders should alert on ConnectWise app-ID role self-assignment or credential addition regardless of source IP, and count distinct records read per identity over time rather than volume thresholds. Generic indicators such as curl user agents should only add warnings, never fire alone. Note that Zeek cannot observe sign-ins.

For security analysts · Written by AI from 1 source · Report an error

Sources
1

Sources and verification

Sources and editorial review

No named human review has been recorded for this story. See the source evidence below.

No vendor or government source is linked to this story yet. Read the source reports; attribution is not independent verification.

How severity and exploitation labels work · All source reports · Report an error

What to do

  1. Deploy the behavioural Sigma and Sentinel rules from the pack rather than relying only on IOC lists.
  2. Alert on role self-assignment or credential addition in Entra ID regardless of source IP.
  3. Treat generic indicators such as curl user agents as warnings only, not as standalone alerts.
  4. Verify indicators through human review before acting on them.

Written by AI from the sources, checked against them

Source timeline (UTC) · 1 update

  1. Mon 16 NovemberFrom Report to Tested Detection in Hours: The ARTEX Signature PackSecurity Affairs

Explore this report

Ask AI about this story

Optional follow-up answers generated from our coverage. Check the linked sources before acting.

Ask your own question

Who and what is in it

Companies

Products

Report a problem